Summary & Overview
HCPCS G9561: Patients Prescribed Opiates Longer Than Six Weeks
HCPCS Level II code G9561 designates patients who have been prescribed opioid medications for periods longer than six weeks. This code is intended to flag patients on chronic opioid therapy for purposes such as care management, quality measurement, and appropriate follow-up. Nationally, identifying prolonged opioid use remains a priority for clinical safety initiatives and payer oversight given risks of dependence, overdose, and the need for monitoring.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical purpose, typical sites of service, and how payers commonly address prolonged opioid prescribing in coverage and quality programs. The publication also outlines benchmarks and policy-relevant considerations tied to coding for long-term opioid therapy, and provides context for clinical documentation and claims reporting where available.
This summary serves clinicians, billing staff, and policy stakeholders seeking a concise national perspective on G9561, its clinical intent, and the payer environment that governs reporting and oversight of extended opioid prescriptions.
Billing Code Overview
HCPCS Level II code G9561 identifies patients who have been prescribed opiates for longer than six weeks. The service type is chronic opioid therapy assessment/identification, focusing on ongoing opioid use that exceeds six weeks. The typical site of service is outpatient clinical settings, including primary care offices, pain management clinics, and behavioral health clinics where long-term opioid prescribing is managed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 54-year-old patient with chronic low back pain has been prescribed opioid therapy by their primary care provider for the past nine months. The patient attends a scheduled follow-up visit in an outpatient primary care clinic to review ongoing opioid therapy, assess pain control, evaluate functional status, screen for opioid use disorder risk, and consider dose adjustment or tapering. The clinical workflow includes medication reconciliation, pain and functional assessment, review of Prescription Drug Monitoring Program (PDMP) data, urine drug testing if indicated, documentation of informed consent and treatment agreement, and coordination with pain management or behavioral health specialists as needed. Typical documentation captures duration of opioid use (>6 weeks), current medications and dosages, risk stratification, rationale for continued therapy, and any changes to the treatment plan. Typical site of service is outpatient office or ambulatory care; services may also occur in pain clinics or primary care clinics. Common payors include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to manage complex opioid therapy (administrative burden, extended documentation) substantially exceeds typical visits. |